Ying Huang, Legend Biotech CEO
May 27, 2021 08:50 AM EDT
Cell/Gene Tx
FDA+

FDA steers J&J/Leg­end CAR-T to a quick de­ci­sion as part­ners prep a loom­ing show­down with Bris­tol My­ers, blue­bird

John Carroll

Editor & Founder

Just days af­ter in­ves­ti­ga­tors post­ed a jaw-drop­ping set of pos­i­tive up­dat­ed da­ta for the BC­MA CAR-T cil­ta-cel — or JNJ-4528 — J&J’s part­ners at Leg­end are …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump’s sci­ence crack­down hits rare dis­ease re­search: ‘We need to sit down with Elon Musk’

Where the mon­ey is: The top 100 ven­ture in­vestors in biotech

At least sev­en drug­mak­ers say they will par­tic­i­pate in round two of IRA ne­go­ti­a­tions 

Can Bill An­der­son save Bay­er?

Ex­clu­sive: In­fec­tious dis­ease doc­tors con­sid­er 'mi­ni-ACIP' if RFK erodes CDC vac­cine pan­el

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times